NCT02925650 - Safety, Tolerability, PK and PD of Posiphen® in Subjects With Early Alzheimer's Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 2, 2017

Primary Completion Date

December 10, 2021

Study Completion Date

December 31, 2021

Conditions

Alzheimer's Disease

Interventions

DRUG

Posiphen

oral solid dosage form capsule

DRUG

Placebo

oral solid dosage form capsule

Trial Locations (6)

Columbia University Medical Center Sergievsky Center Taub Institute, New York

Johns Hopkins Hospital, Baltimore

Cleveland Clinic, Cleveland

IU Health Partners, Adult Neurology Clinic, Indianapolis

Washington University Sleep Medicine Center, Brentwood

UCSD Alzheimer's Disease Research Center, La Jolla